Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Respiratory Distress Syndrome Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Respiratory Distress Syndrome 30
May 22, 2018: Windtree Receives $0.7 Million SBIR Grant in Continuing Support of the AEROSURF Phase 2b Clinical Trial Completion 30
Clinical Trial Profile Snapshots 31
Appendix 201
Abbreviations 201
Definitions 201
Research Methodology 202
Secondary Research 202
About GlobalData 203
Contact Us 203
Source 203

List of Tables
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Region, 2018* 7
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Respiratory Distress Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 10
Respiratory Distress Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 11
Respiratory Distress Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2018* 12
Respiratory Distress Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 13
Respiratory Distress Syndrome Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 14
Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials, G7 Countries (%), 2018* 15
Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials, E7 Countries (%), 2018* 18
Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Phase, 2018* 21
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 22
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Respiratory Distress Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 26
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29

List of Figures
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9
Respiratory Distress Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 10
Respiratory Distress Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 11
Respiratory Distress Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 12
Respiratory Distress Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 13
Respiratory Distress Syndrome Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 14
Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials, G7 Countries (%), 2018* 15
Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Respiratory Distress Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Proportion of Respiratory Distress Syndrome to Respiratory Clinical Trials, E7 Countries (%), 2018* 18
Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 19
Respiratory Distress Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 20
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2018* 21
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 22
Respiratory Distress Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 23
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 24
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 25
Respiratory Distress Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 26
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 27
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 28
Respiratory Distress Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 29
GlobalData Methodology 202

Companies Mentioned
- Windtree Therapeutics Inc
- Chiesi Farmaceutici SpA
- GlaxoSmithKline Plc
- MallInckrodt Plc
- THERAMetrics holding AG
- Savara Inc
- Faron Pharmaceuticals Oy
- F. Hoffmann-La Roche Ltd
- Bayer AG
- Allergan Plc